BTK inhibitor：BTK Inhibitors in Chronic Lymphocytic Leukemia
BTK Inhibitors in Chronic Lymphocytic Leukemia
由MPalma著作·2021·被引用39次—Bruton´styrosinekinase(BTK)inhibitor(BTKi)sblocktheB-cellreceptor(BCR)signalingcascadebybindingtotheBTKenzymepreventing ...。其他文章還包含有：「被套細胞淋巴瘤的生力軍」、「BrutonTyrosineKinaseInhibitor」、「Bruton'sTyrosineKinaseInhibitors(BTKIs)」、「TheDevelopmentofBTKInhibitors」、「BTKinhibitorsinthetreatmentofhematologicalmalignancies...」、「Preclinicalc...
查看更多 離開網站
被套細胞淋巴瘤的生力軍
https://jtp.taiwan-pharma.org.
近年來作用在B細胞表面抗原受器路徑中的Bruton's tyrosine kinase (BTK) 抑制劑，臨床上有不錯的效果與耐受性，在復發或頑固型的被套細胞淋巴瘤上提供了 ...
Bruton Tyrosine Kinase Inhibitor
https://www.sciencedirect.com
Bruton tyrosine kinase (BTK) inhibitors interfere with B-cell signaling by inhibiting BTK, an enzyme critically involved in B cell maturation upon B-cell ...
Bruton's Tyrosine Kinase Inhibitors (BTKIs)
https://www.ncbi.nlm.nih.gov
Currently, the U.S. Food and Drug Administration (FDA) has approved three BTK inhibitors: ibrutinib (2013), acalabrutinib (2017), and ...
The Development of BTK Inhibitors
https://www.ncbi.nlm.nih.gov
Branebrutinib is a highly selective covalent, irreversible BTK inhibitor (IC50 = 0.1 nM) with rapid target inactivation in vivo. In a low human ...
BTK inhibitors in the treatment of hematological malignancies ...
https://jhoonline.biomedcentra
Clinically approved BTK inhibitors. Five BTKi have been approved for use in humans, including ibrutinib, acalabrutinib, zanubrutinib, ...
Preclinical characterization of pirtobrutinib
https://pubmed.ncbi.nlm.nih.go
However, approved covalent BTK inhibitors (cBTKis) are associated with treatment limitations because of off-target side effects, suboptimal oral ...
How BTK inhibitors treat mantle cell lymphoma
https://www.mdanderson.org
BTK inhibitors are a type of drug that work to treat cancers caused by defective B cells, such as chronic lymphocytic leukemia, B-cell lymphomas ...
Bruton tyrosine kinase inhibitors for multiple sclerosis
https://www.nature.com
Bruton tyrosine kinase (BTK) inhibitors directly modulate the functions of B cells and myeloid cells (including macrophages and microglia) and ...
Selecting the optimal BTK inhibitor therapy in CLL
https://pubmed.ncbi.nlm.nih.go
Bruton's tyrosine kinase (BTK) inhibitors have dramatically changed the treatment of newly diagnosed and relapsed/refractory chronic ...